We are live on ! Find out more
PLRX icon

Pliant Therapeutics
PLRX

76 hedge funds and large institutions have $1.21B invested in Pliant Therapeutics in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

86% more capital invested

Capital invested by funds: $648M → $1.21B (+$560M)

25% more funds holding

Funds holding: 61 → 76 (+15)

5.58% more ownership

Funds ownership: 80.37% → 85.95% (+5.6%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
76
Holders Change
+15
Holders Change %
+24.59%
% of All Funds
1.33%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
29
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$26.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$19.3M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.95M
4
State Street
State Street
Massachusetts
+$6.47M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.47M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$11.9M
2
RG
Redmile Group
California
-$5.88M
3
LGM
Logos Global Management
California
-$1.74M
4
CA
CHI Advisors
New York
-$974K
5
PCM
Pentwater Capital Management
Florida
-$341K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
26
Grace Capital
Massachusetts
$1.48M +$984K +30,308 +386%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$1.43M +$665K +20,464 +130%
Wells Fargo
28
Wells Fargo
California
$1.22M +$498K +15,350 +98%
PCM
29
Pentwater Capital Management
Florida
$1.18M -$341K -10,500 -26%
JP Morgan Chase
30
JP Morgan Chase
New York
$1.17M +$812K +25,014 +535%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$1.01M +$359K +11,044 +76%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$946K +$448K +13,798 +135%
Swiss National Bank
33
Swiss National Bank
Switzerland
$944K – – –
AllianceBernstein
34
AllianceBernstein
Tennessee
$912K +$753K +23,200 New
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$735K +$299K +9,200 +97%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$661K -$50.2K -1,547 -8%
Deutsche Bank
37
Deutsche Bank
Germany
$620K +$260K +8,004 +103%
Goldman Sachs
38
Goldman Sachs
New York
$579K -$109K -3,348 -19%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$578K – – –
TD Asset Management
40
TD Asset Management
Ontario, Canada
$568K +$469K +14,442 New
DCM
41
Dupont Capital Management
Delaware
$545K +$64K +1,971 +17%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$525K +$434K +13,349 New
BFM
43
Boothbay Fund Management
New York
$501K +$414K +12,740 New
ProShare Advisors
44
ProShare Advisors
Maryland
$446K +$368K +11,328 New
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$443K – – –
VEA
46
Virtus ETF Advisers
New York
$431K +$6.2K +191 +2%
VOYA Investment Management
47
VOYA Investment Management
Georgia
$407K +$336K +10,338 New
MIM
48
MetLife Investment Management
New Jersey
$374K +$150K +4,633 +95%
Principal Financial Group
49
Principal Financial Group
Iowa
$340K +$280K +8,635 New
CS
50
Credit Suisse
Switzerland
$322K +$266K +8,192 New
1
2
3 4

PLRX Hedge Fund Activity: Q1 2021 in Review

76 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q1 2021, worth a combined $1.21B — up 86% from $648M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new PLRX positions and 4 closed out — a net gain of 15 holders — while 29 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $26.6M. The largest seller was Eventide Asset Management, cutting an estimated $11.9M.

  • 76 institutional investors held Pliant Therapeutics (PLRX) as of Q1 2021, up from 61 in Q4 2020.
  • Funds reported $1.21B of Pliant Therapeutics stock for Q1 2021, up 86% quarter-over-quarter.
  • 19 funds opened new Pliant Therapeutics positions in Q1 2021 and 4 closed out, a net change of +15 holders.
  • The largest Pliant Therapeutics buyer in Q1 2021 was BlackRock, an estimated $26.6M added.
  • The largest Pliant Therapeutics seller in Q1 2021 was Eventide Asset Management, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2021.